distal radius, after the age of 50, is 40% for white women and 15% for white men. Osteoporosis treatment costs American Health Administration about 10 billion dollars a year, that again is without taking into account the costs of long-term treatment at home. Up to 50% of the patients with fractures of the proximal femur cannot live without outside help. Fifteen to 20% of these patients die within the first year.
The number of osteoporotic fractures worldwide is showing an increasing tendency. From 1.7 million cases registered in 1990 it is expected to reach a figure of 6.3 million in the year 2050. ( 2) The seriousness of the osteoporosis problem is aggravated by the absence of effective, simple and harmless medicinal therapy. The effectiveness of any of the existing treatment is rather low, and only a small percentage of increase in the bone mass tends to be achieved. (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) We have developed our own methods of energyinformational therapy for osteoporosis using a systematic principle to influence and stimulate the reparative process. Our method is based on a nonstandard approach to solving the osteoporosis problem. All medical therapies view either osteoclasts as their target, with a view to reducing their activity, or osteoblasts, with the intention of increasing their activity. These treatment strategies are all based on the principle of addition and substitution of functions of the organism and, therefore, lead to the exhaustion of the body's own resources and, consequently, necessitate the constant ingestion of medications.
We regard the human organism as a complete self-regulating open system, striving for minimization of entropy and energy losses. A disease is a disorder of the energy-related activities in the body, by various systems of organs and cells, leading to some distortions in various essential processes of biosynthesis within the cells. During the course of life beginning from birth, the body's capacity for energy production grows alongside the growth of the skeleton and the bone mass. After the age of 30-35, both the body's energy capacity and bone mass tend to decrease. Reduction in energy capacity is accompanied by the reduction of functions of various organs and systems, and the deterioration of functional activities of the whole body leading to various diseases resulting in aging and further reduction of the bone mass. This is an uneven process: starting from one stable energetically functional condition to another stable but less powerful energy level. Functional activities and capabilities tend to decrease right up to death . Therefore, in order to stop the process of aging and reduction of the bone mass, two things are required.
First and foremost it is essential not to substitute for the body's functions but to activate them by using something appropriate to the energy-informational processes taking place within it. In our Treatment System, this is done by using the methods of low reactive level laser therapy (LLLT) coupled with magnetic and microwave (extremely-high frequency) therapies. They imitate natural physical factors such as: the radiation of the Sun and the magnetic field of the Earththe two necessary conditions for the existence of life. A single quantum of energy has the theoretical potential to launch biosynthesis and give birth to a great number of oscillating energy-informational processes, with microwaves being one of their components. Secondly, it is vital to activate and restore the structures and functions of the body, the failures of which lead to dysfunction of both osteoclasts and osteoblasts resulting in further deterioration of the osteoporotic condition.
Subjects and Methods
We believe that each osteoporosis-related pathological condition has its specific causes. For all that, we are interested in both qualitative and quantitative characteristics of the organic etiopathogenesis.
By using our complex Diagnostics System, we identify the following: 1) Osteoporosis and both its current stage (by dual energy bone densitometry), and the the bone metabolic condition (by bone metabolism markers) 2) The causes of each case of osteoporosis, and the general condition of the whole body (by infrared thermography, Foll's electro-puncture diagnostics, vegetative-resonance diagnostics, ultrasound diagnostics, laboratory diagnostics and functional diagnostics), and 3) The energy conditions of the acupuncture channels (by pulse-analytical diagnostics, Nakatani's electropuncture diagnostics). After completion of the diagnostic program we treat patients with MEGA LASER, our own patented equipment "Medical system for energy-informational therapy of osteoporosis, Dr. Kulykovych". (Fig. 1 ) Our aims are: 1. To activate the functional conditions of various systems of the body participating in calcium metabolism, such as the kidneys, the endocrine system and the alimentary tract. This is achieved by informational correction of energy channels, effected by the application of extremely high frequency ultrasound energy (10-40 GHz, average power 3 mW) (Fig. 2 ) through an appropriate puncture; and, , 2. At the same time to normalize regulation of the cen-tral functions of the brain and, simultaneously, restore the neuroendocrine and neurovegetative innervations, which is achieved by auricular electropuncture (30-70 mkA), bioresonance opthalmo-color laser therapy (color impulse stimulation by a visible spectrum + a modulating GaAs laser of 1300 nm, 0.5 mW, 3min., 0.18J/cm 2 ) and intravenous dual-wave laser therapy (GaAs, 633 nm 2-5 mW + GaAs, 785 nm 2-10 mW; 20min., 1-5 J/ cm 2 ). and 3. To activate the microcirculation, metabolism and regenerative processes in the functionally weak and pathologically changed organs and joints (kidneys, liver, intestines, spine, large joints, flat bones and ribs), which we accomplish by the use of: a) A three-wave scanning laser: to influence external structures: (GaAs, 635 nm, 25 mW + GaAs, 785 nm, 50 mW + GaAs, 850 nm, 30mW; 5min. per zone, 0.3J/ cm 2 ), b) A contact laser with a rotating space orientation to influence deep internal parts (GaAs, 905 nm, 300 W; 3min., 1 J/ cm 2 ); c) The same contact-point pulsed laser (GaAs, 905 nm, 60 W; 10min., 15 J/ cm 2 ) system with an axially rotating magnetic field: (100 mTl ) to influence the trigger zones and deep parenchymal organs, d) A bioresonance light-color-laser system with a rotating magnetic field, particularly for large joints, spine, and projections of external organs laser, (GaAs, 905 nm, 60 W; 10min., 0.5 J/ cm 2 same as above) + blue-red-yellow-green light of 500 lux + a magnet of 100 mTl), e) An extra-venous three-wave bioresonance lighting system for blood and large joints (GaAs, 635 nm, 10 mW + GaAs, 785 nm, 40 mW + 905 nm, 60 W; 5min., 10 J/ cm 2 ) and; f) A magnetic low-intensive bioresonance system for exerting influence on the bone mass (0.1-1 mTl).
A complex medical session typically lasts for about one hour. The whole course of this ambulatory treatment usually lasts for about 15 to 20 sessions, which can be given on consecutive days, or on alternate days.
All patients are given individualized compulsory recommendations on nutrition with a daily consumption of calcium of not less than 0.4 g. We are advocates of natural consumption of calcium. If the patient cannot consume dairy products and sesame, he/she must take calcium tablets in the quantity of 0.5 g a day (17) .
We have analyzed 180 cases of osteoporosis patients who underwent treatment in our Clinic during 1999 to 2006. This sample is composed of 136 females and 44 males. The breakdown of the patients by age group is as follows: 49 yr and under, 75 patients; 50-65 yr, 66 patients; and 65-80 yr, 39 patients. In this sample, there were 91 idiopathic, 50 postmenopausal, and 39 senile osteoporosis cases. We used the data of bone densitometry obtained by the Dual-Energy X-ray Absorptiometry (DEXA), in the evaluation of the criteria of the effectiveness of our treatment. The examination was carried out using a Lunar DPX-MD (USA). We analyzed the lumbar and proximal femur BMD with the anteroposterior (AP) and lateral-projection methods. Statistical analysis was performed with the Student's t-test, based on the difference between the real (BMD) and an average theoretical peak of a normally distributed BMD. The examinations were performed at baseline (before the initiation of the treatment), and also during a span of 3 years after completion of the treatment.
Analysis of variance (ANOVA), complemented by the Bonferroni test, was performed to verify if significant differences (p < 0.05) were observed.
Results and Discussion
With postmenopausal osteoporosis cases, the average BMD growth was 15% at 13 months after treatment. With elderly patients the average BMD growth was 21% at 12.6 months after treatment. With patients suffering from idiopathic osteoporosis, the average BMD growth was 16.1% in 12.9 months, which was statistically significant (p <0.05 before treatment vs. after treatment) (Table 2) . PreTx---Before Treatment, PostTx---After Treatment, AvFU---Average Posttreatment Follow-up period BMD growth was accompanied by improvement in the general health, neuro-vegetative conditions, psycho-emotional and metabolic endocrine status, the ability to work and the social activity of the patients. Apparently, it was caused by the improvement in the general hormonal conditions, the level of hormone growth in the system, as well as an increase in local trophic factors, such as the improvement in the functionality of the kidneys. These improvements were monitored by a series of positive observations in the the urine and blood chemoanalyses.
By analyzing this group of patients, we noticed that the results obtained during the period [2003] [2004] [2005] [2006] were much better than those of 1999-2002, which is undoubtedly due to our more advanced equipment as well as the improved methods of treatment (Table 3) as a result of our continuous research and innovation efforts. Analyzing the BMD growth correlated with the time lapsed since the completion of the treatment, we found out that BMD growth was accelerated in the course of the first 6 to 7 months follow-up after treatment, and then it gradually tapered down in the course of the next 12-16 months (Table 4) . Based on these data, we can conclude that, during this period, anabolic processes prevail over catabolic processes, thus most likely stopping the process of aging. We continue to advise our patients to repeat a course of treatment after each period of 6 to 12 months, so as to avoid disease and sustain the general quality of life.
Comparison of the BMD growth for the men and women we treated is not quite appropriate, since women represent a far more heterogeneous group (Table 5) . Comparison of the BMD growth in terms of the stage of osteoporosis showed an interesting tendency: the lower the BMD, the better the results of the treatment. The following correlation was also noted, the higher the weight of the patient, the better the effects of treatment. The worse the functional conditions of the organs, the more dysfunctional were the energyinformational systems of the patient, and, consequently, the more sensitive they became to the energy-informational correction.
This proves once again that a human body is an open self-regulating 'intelligent' system, and it can be quickly restored to its optimal conditions by using adequate amount of appropriate therapy (Table 6 ). Analyzing the BMD growth using the densitometry projection, we could observe a higher BMD growth in various parts of the vertebrae. Cancellous bone changes were more dynamic than those taking place in the cortical bone (Table 7) . However, we have a unique case relating to the increase of the BMD of the proximal femur bone which reached the figure of 49.8% within only a year and a half. A 29-year old patient with 'secondary' osteoporosis, and with additional complications due to acute stone formation in the bladder and kidney, who presented after a kidney operation and with chronic calculary pyelo-nephritis, sought our advice and assistance in 2001. She was not able to move independently. Her husband carried her into our clinic in his arms. She underwent 4 courses of treatment, with a total of 59 medical sessions, during a period of one and a half years. After the completion of each course of treatment, her functional abilities were fully restored. Her kidney tests also stabilized.
After a thorough analysis we have picked out a group of 34 patients with exceptional results. These are the patients with a very high BMD growth from 30 to 90 % (Fig. 3-Fig. 5, Table 8-17) . This can most likely be explained by the following three factors: 1) All these patients underwent a long-term course of NEW INTEGRATIVE METHOD OF OSTEOPOROSIS treatment, 20 and more medical sessions, and, correspondingly received more fundamental correction of their various conditions.
2) All of them were treated during the latter period when our methods had considerably improved. 3) All of them had an initially substantially low BMD. The most astonishing fact is that the results of treatment do not depend on the patients' age. We tend to have the hypothesis that: "The human body is able to restore its functions at any age".
For evaluation of bone metabolism we used the markers of the Nordic Bioscience Diagnostics (Denmark): namely the Serum Cross-Laps One
Step which is the marker of bone tissue resorption, and NMid Osteocalcin levels, the marker of bone tissue synthesis.
Pre and post-treatment examinations were carried out on the Austrian "Anthos 2020" photometer simultaneously with osteo-densitometry. We started this program in 2005 and we have obtained the results only for 18 patients so far. But even the first results show that the BMD growth is accompanied by positive dynamics in the bone metabolism markers (Table 18 ). To evaluate the intensity of the pain syndrome and the level of its reduction during the course of our treatment, we used visual analogue (Fig. 6 ) and verbal-ranking-evaluation scales (Table 19) . For all types of osteoporosis obvious pain control effect of the energy-informational therapy was clearly seen. This effect was achieved quickly in the course of our treatment, and at the first stage, it was not connected with the BMD growth. The main mechanism of analgesia were probably an increase in the development of some endogenous opiate-endorphins, and then, at the second stage, the analgesic effect was sustained by a gradual growth of BMD and the strength of the skeleton.
And finally, none of our patients developed any fresh fractures in the course of 3 years after the completion of treatment. 
NEW INTEGRATIVE METHOD OF OSTEOPOROSIS

Conclusions
In the research data presented in this paper we have proved the efficiency of a nonstandard approach to solving the osteoporosis problem. Etiopathogenic treatment of the whole body with the application of our equipment, and not only of its parts, combined with the application of various types of laser, magnetic and microwave energy allowed us to treat osteoporotic patients without harmful side effects, and by increasing the BMD, reducing the pain syndrome, and averting the usual fractures, which consequently improved the quality of life of our patients as well as their general life expectancy. We believe that the data from the present study show that our methods of treatment could be proved to be a better and more effective alternative to any other existing method of treatment for osteoporosis at the present moment.
